The company has significantly improved the progress of a novel treatment for ATTR-CM, employing the investigational drug. Preliminary patient information suggests potential benefits for those diagnosed by a severe https://attruby713396.thenerdsblog.com/48266767/bridgebio-improves-amyloidosis-management-using-attruby